The present invention is directed C2-disubstituted indan-1-ones of the
Formula I, ##STR00001## physiologically acceptable salts, and
physiologically functional derivatives thereof, and pharmaceutical
compositions comprising such compounds, salts and derivatives, which are
useful for reducing weight, for the prophylaxis or treatment of obesity,
and for the prophylaxis or treatment of type II diabetes in mammals. The
invention is directed also to methods for reducing weight and such
treatments and prophylaxis. The invention is directed also to processes
for the preparation of such compounds.